5-Methyl-2-Pyrazinecarboxylic Acid CAS 5521-55-1 Purity >99.0% (HPLC)

Name: 5-Methyl-2-Pyrazinecarboxylic Acid Synonyms: 5-Methylpyrazine-2-Carboxylic Acid CAS: 5521-55-1 Purity: >99.0% (HPLC)  Appearance: Off-White Crystallized Powder High Quality, Commercial Production E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureShanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Item Specifications
Appearance Off-White Crystallized Powder
Purity / Analysis Method >99.0% (HPLC)
Melting Point 164.0~168.0℃
Water (by Karl Fischer) <0.50%
A Single Impurity <0.50%
Total Impurities <1.00% 
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediate; Acipimox Intermediate

Description:

Specifications:

Package & Storage:

Chemical Name 5-Methyl-2-Pyrazinecarboxylic Acid 
Synonyms 5-Methylpyrazine-2-Carboxylic Acid 
CAS Number 5521-55-1
CAT Number RF-PI2146
Stock Status In Stock, Production Capacity 20 Tons/Month
Molecular Formula C6H6N2O2  
Molecular Weight 138.12
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) is an important pharmaceutical intermediate, is mainly used for Acipimox intermediate. Acipimox is a potent long-acting antilipolytic nicotinic acid (NA) analog. Like nicotinic acid, acipimox lowers lipids effectively, but unlike nicotinic acid, acipimox is longer acting and therefore much less prone to produce free fatty acid rebounding. Acipimox is recommended as a lipid-lowering agent to treat hyperlipidemia in patients with noninsulin dependent diabetes mellitus. Acipimox is a hypolipidemic agent related to nicotinic acid with pronounced, longlasting antilipolytic activity. In addition to its lipid lowering activity, it produces a beneficial elevation of the anti-atherogenic high density lipoprotein subfraction, HDL2. 

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours